Jounce Therapeutics, Inc.
JNCE · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51 | -$91 | -$44 | $57 |
| Dep. & Amort. | $2 | $3 | $3 | $4 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $10 | $11 | $10 | $10 |
| Change in WC | $9 | -$8 | $3 | -$99 |
| Other Non-Cash | $1 | $1 | $0 | -$1 |
| Operating Cash Flow | -$29 | -$83 | -$28 | -$30 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$25 | -$130 | -$86 | -$189 |
| Inv. Sales/Matur. | $109 | $70 | $137 | $221 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $83 | -$61 | $51 | $31 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $91 | $70 | $4 |
| Stock Repurch. | $0 | $0 | $56 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $92 | $71 | $4 |
| Financing Cash Flow | $0 | $92 | $71 | $4 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $55 | -$52 | $94 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $97 | $149 | $55 | $49 |
| End Cash | $152 | $97 | $149 | $55 |
| Free Cash Flow | -$30 | -$84 | -$28 | -$31 |